文献速递头颈部肿瘤放疗

头颈癌预后预测模型在放疗患者中的外部验证:地理多样人群中的泛化性评估及老年患者考量

External validation of a head & neck cancer outcome prediction model in radiotherapy patients: Evaluating generalisability in a geographically diverse population, with particular consideration of older patients.
PubMed 文献 · Radiother Oncol · 2026-08-04

本研究在澳大利亚六中心502例头颈鳞癌放疗患者中外部验证丹麦多终点预后模型,预测3年局部区域失败、远处转移和无病生存死亡。模型AUC分别为0.66、0.73和0.73,老年亚组表现相似,高风险组校准略有偏差,提示模型具有泛化性。

要点

  • 丹麦HNSCC预后模型在澳大利亚人群中验证,3年LRF、DM和Death NED的AUC分别为0.66、0.73和0.73。
  • 老年(≥70岁)亚组模型表现与全队列相似,提示模型在该亚组公平适用。
  • 模型可区分LRF和DM的低、中、高风险组,但高风险组校准略有偏差。

核心结论

  • 该丹麦HNSCC预后模型在澳大利亚人群中表现一致,在老年患者中亦表现一致,显示其泛化性,可作为支持个体化预后讨论和治疗决策的实用工具。

研究设计与样本

  • 回顾性外部验证研究,使用澳大利亚六个中心接受治疗的患者数据,验证预测3年局部区域失败、远处转移和无病生存死亡的多终点模型。

主要发现

  • 全队列(n=502)3年AUC:LRF为0.66(95%CI 0.60-0.73),DM为0.73(95%CI 0.65-0.80),Death NED为0.73(95%CI 0.66-0.79)。
  • 老年亚组获得与全队列相似的AUC值。
  • 竞争风险亚分布风险比显示模型可区分LRF和DM的低、中、高风险组。
  • 校准图显示LRF和Death NED的高风险组存在轻微校准偏差。

关键数值与推荐

  • 模型性能评估指标包括AUC、Brier评分、校准图和竞争风险亚分布风险比。
  • 验证在老年患者(≥70岁)亚组中额外进行,以检验模型公平性。

临床怎么用

  • 该模型可用于支持围绕预后和治疗的个体化讨论,尤其适用于需要调整治疗的老年患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Outcome prediction models for Head and Neck Squamous Cell Carcinoma (HNSCC) may be useful for clinical decision support. Prior to clinical use, multiple independent external validations are important to demonstrate generalisability in different populations. This study aimed to externally validate a Danish HNSCC outcome prediction model in an Australian patient population, treated using different treatment guidelines and evaluate validation in older (70 + years) patients. METHODS: Retrospective data from patients treated at six Australian centres were used to validate a multi-endpoint model predicting 3-year locoregional failure (LRF), distant metastases (DM) and death without evidence of disease (death NED). Model performance was assessed using Area Under Curve (AUC), Brier score, calibration plots and subdistribution hazard ratios for competing risks. Model validation was also undertaken in older patients (≥70 years) to examine model fairness in this subgroup. RESULTS: For the full cohort (n = 502), 3-year AUC values were 0.66 (95 % CI 0.60-0.73) for LRF, 0.73 (0.65-0.80) for DM and 0.73 (0.66-0.79) for Death NED. Similar values were obtained for the older subgroup. Subdistribution hazard ratios demonstrated the model could distinguish low, intermediate, and high-risk groups for LRF and DM. Calibration plots exhibited slight miscalibration in the high-risk groups for LRF and Death NED. CONCLUSION: The model demonstrated consistent performance in an Australian population compared to the Danish development cohort, and in older patients, highlighting its generalisability. It may serve as a practical tool to support personalised discussions around prognosis and treatment, particularly for older patients requiring treatment modifications.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Aly F, Descallar J, Robledo K, et al. External validation of a head & neck cancer outcome prediction model in radiotherapy patients: Evaluating generalisability in a geographically diverse population, with particular consideration of older patients. Radiother Oncol. 2026. PMID: 42551637. doi:10.1016/j.radonc.2026.111714

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。